Literature DB >> 3706887

Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.

D E Craven, L M Kunches, V Kilinsky, D A Lichtenberg, B J Make, W R McCabe.   

Abstract

We studied risk factors for nosocomial pneumonia and fatality in 233 intensive care unit patients requiring continuous mechanical ventilation. Ventilator-associated pneumonia was diagnosed in 49 (21%) of the 233 patients. Of the 8 risk factors univariately associated with the development of pneumonia, only the presence of an intracranial pressure monitor (p less than 0.002), treatment with cimetidine (p less than 0.01), hospitalization during fall-winter seasons (p less than 0.04), and mechanical ventilator circuit changes every 24 h rather than every 48 h (p less than 0.02) remained significant after stepwise logistic regression. The overall fatality rate for the 49 patients who developed ventilator-associated pneumonia was 55%. Ventilator-associated pneumonia was 1 of 18 variables univariately associated with overall patient fatality, but it was not among the 7 variables present after multivariate analysis. The data delineate risk factors associated with the development of nosocomial pneumonia and fatality in patients receiving continuous mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706887

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  96 in total

1.  Uncertain relevance of gastric colonization in the seriously ill.

Authors:  J F Cade; E McOwat; R Siganporia; C Keighley; J Presneill; V Sinickas
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Evaluation of conventional weaning criteria in patients with acute respiratory failure.

Authors:  K Okamoto; H Iwamasa; H Dogomori; T Morioka
Journal:  J Anesth       Date:  1990-07       Impact factor: 2.078

Review 3.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

4.  Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report.

Authors:  L A Mandell; T J Marrie; M S Niederman
Journal:  Can J Infect Dis       Date:  1993-11

Review 5.  Drug treatment of pneumonia in the elderly: efficacy and costs.

Authors:  E Saltiel; S Weingarten
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

6.  Selective decontamination of the digestive tract: effect of cessation of routine application at an ICU.

Authors:  H A Tissot van Patot; J A Leusink; J Roodenburg; B M de Jongh; H S Lau; S de Boer; A de Boer
Journal:  Pharm World Sci       Date:  1996-10

7.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

8.  Role of bronchoalveolar lavage in mechanically ventilated patients with suspected pneumonia.

Authors:  J Vallés; J Rello; R Fernández; L Blanch; F Baigorri; J Mestre; L Matas; A Marín; A Artigas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 9.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 10.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.